ClearPoint Neuro CEO Buys Shares After Selling at Premium, Signals Balanced Insider Confidence【News Flash】
ClearPoint Neuro CEO’s 20‑share buy‑sell pattern under a 10b5‑1 plan shows balanced confidence—sell at premium, buy low, and hold a sizable stake as the company pushes biopharma growth.
3 minutes to read